Perceval S sutureless valve for aortic valve replacement: a review of the clinical effectiveness, safety, and cost-effectiveness
CADTH
Record ID 32016000120
English
Authors' recommendations:
Based on preliminary results from single-arm studies and small non-randomized comparisons with alternative methods for valve replacement, sutureless valve implantation has a high initial success rate, with low rates of in-hospital death, strokes, endocarditis, and renal failure. Rates of paravalvular regurgitation and heart arrhythmias leading to pacemaker implantation are raised compared to standard surgical valve implantation. However, long-term evidence on valve stability, durability, and safety are lacking, and criteria for selecting the best procedure for patients who are also potential candidates for conventional surgery or TAVI.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
http://www.cadth.ca/sites/default/files/pdf/htis/feb-2015/RC0625_PercevalS_Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Rapid Review
Country:
Canada
MeSH Terms
- Aortic Valve
- Bioprosthesis
- Heart
- Heart Valve Prosthesis
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.